In vitro and in vivo studies on NPC cells have shown that calycosin can reduce tumor growth and cell proliferation by decreasing the expression of EWSAT1 and its downstream genes, including p-TAK1, TRAF6, and p-IκBα [124]. Here, EWSAT1 is linked to nasopharyngeal carcinoma.